Chimeric immunoglobulin with CDR loop substituted for T-and/or B-cell epitope; chimeric antibody engineering with virus T-lymphocyte or B-lymphocyte epitope insertion in complementarity determining region loop, for use as a recombinant vaccine or diagnostic agent : Mount Sinai Sch. Med.; Univ. New York City World 9619 584; 27 June 1996